SBC-201

N/A

Report date: 2024/11/19 11:38:14

Base Information

Drug NameSBC-201
Drug Alias NameSBC-201SBC201
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeurodegenerative Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSunRegen Healthcare AG
China Registration ClassN/A

Develop Information

Active CompaniesSunRegen Healthcare AG
Inactive CompaniesN/A
Active IndicationsNeurodegenerative Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A